ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Decides To Accept NCAB Recommendation, Award Organ Systems Coordinating Center to Roswell Park

July 6, 1984

Toxicology Program Board To Review Nine Substances.

January 14, 2000

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

ASCB Annual Awards, Honors.

January 7, 2000

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993